Rimegepant Calcitonin gene-related peptide (CGRP) receptor antagonist Treatment of migraine

Lionetto, L; Capi, M; Curto, M; Cipolla, F; Guglielmetti, M; Martelletti, P

Martelletti, P (reprint author), Reg Referral Headache Ctr, Dept Clin & Mol Med, Via Grottarossa 1035, I-00189 Rome, Italy.

DRUGS OF THE FUTURE, 2019; 44 (8): 635

Abstract

Rimegepant is an oral calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under development by Biohaven Pharmaceuticals for th......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索